SHOOK DAVID (Chief Medical Officer) sold 2.4% of their position (500.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $6.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/10/2026ACC: 0001959742-26-000003
Officer· Chief Medical Officer
Since Feb 2026
-500.00
Net shares
Net seller
$6.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
500.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−500.00
Price / share
$12.70
Trade value
$6.35K
% of position
2.4%
9/10/2026
20.92K→20.42K
Total
Net shares
−500.00
Net value
-$6.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | S · Sale | −500.00 | $12.70 | $6.35K | 2.4% | 20.92K | 20.42K |
| Total | −500.00 | -$6.35K | ||||||
Derivative Transactions0
No derivative transactions reported